Women make up two-thirds of people with Alzheimer’s disease and early menopause is a risk factor. A new study in mice shows that activation of a brain protein called CYP46A1 could protect women from developing Alzheimer’s disease. CYP46A1 can be activated by low doses of the anti-HIV drug Efavirenz.

Support the development of it by donating to Patreon or Ko-Fi.